DE69725745D1 - Injizierbare zusammensetzungen - Google Patents
Injizierbare zusammensetzungenInfo
- Publication number
- DE69725745D1 DE69725745D1 DE69725745T DE69725745T DE69725745D1 DE 69725745 D1 DE69725745 D1 DE 69725745D1 DE 69725745 T DE69725745 T DE 69725745T DE 69725745 T DE69725745 T DE 69725745T DE 69725745 D1 DE69725745 D1 DE 69725745D1
- Authority
- DE
- Germany
- Prior art keywords
- warm
- blooded animals
- injectable compositions
- diseases
- moxidecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ286752A NZ286752A (en) | 1996-06-05 | 1996-06-05 | Stable injectable composition of endecticides |
NZ29909396 | 1996-07-30 | ||
PCT/NZ1997/000073 WO1997046204A2 (en) | 1996-06-05 | 1997-06-05 | Injectable compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69725745D1 true DE69725745D1 (de) | 2003-11-27 |
Family
ID=26651622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69725745T Expired - Lifetime DE69725745D1 (de) | 1996-06-05 | 1997-06-05 | Injizierbare zusammensetzungen |
Country Status (7)
Country | Link |
---|---|
US (2) | US6214367B1 (de) |
EP (1) | EP0928136B1 (de) |
AT (1) | ATE252316T1 (de) |
AU (1) | AU728221B2 (de) |
CA (1) | CA2259469A1 (de) |
DE (1) | DE69725745D1 (de) |
WO (1) | WO1997046204A2 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ280086A (en) * | 1995-09-25 | 1997-08-22 | Ashmont Holdings Ltd | Injectable veterinary abamectin composition; also comprises a vegetable oil and an alcohol having 4 or more carbon atoms |
US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US20040208926A1 (en) * | 1997-07-01 | 2004-10-21 | Pfizer Inc | Solubilized sertraline compositions |
US6524592B2 (en) | 1997-10-17 | 2003-02-25 | American Home Products Corporation | Veterinary vaccines |
US7030155B2 (en) | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
NO312056B1 (no) * | 1998-06-09 | 2002-03-11 | Alpharma As Aquatic Animal Hea | Anvendelse av preparater til forebygging og behandling av parasitter hos fisk |
AU781682B2 (en) * | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
US20050009762A1 (en) * | 2003-06-06 | 2005-01-13 | Strobel Michael Albert | Application of water and organic solvent soluble ivermectin for topical and oral use |
US6627613B2 (en) | 2001-07-23 | 2003-09-30 | Michael A. Strobel | Application of water and organic solvent soluble ivermectin for topical and oral use |
KR100600406B1 (ko) * | 2002-07-22 | 2006-07-14 | 주식회사 엘지생명과학 | 주사용 이버멕틴 조성물 및 그 제조방법 |
UY27412A1 (es) * | 2002-08-12 | 2003-06-30 | Carlson Internat Inc | Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn. |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
WO2005094210A2 (en) * | 2004-03-12 | 2005-10-13 | The Hartz Mountain Corporation | Multi-action anthelmintic formulations |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
CN100459864C (zh) * | 2006-05-19 | 2009-02-11 | 东北农业大学 | 多拉菌素、塞拉菌素水乳剂及其制备方法 |
AU2007266475B2 (en) | 2006-05-30 | 2009-12-03 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
DK2049081T3 (da) | 2006-08-09 | 2013-02-25 | Intarcia Therapeutics Inc | Osmotiske leveringssystemer og stempelarrangementer |
PT2157967E (pt) | 2007-04-23 | 2013-04-03 | Intarcia Therapeutics Inc | Formulações de suspensões de péptidos insulinotrópicos e suas utilizações |
CN106310293A (zh) * | 2007-09-27 | 2017-01-11 | 免疫疫苗技术有限公司 | 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用 |
US20100209452A1 (en) * | 2007-10-03 | 2010-08-19 | Immunovaccine Technologies, Inc | Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
EP2296696B1 (de) | 2008-06-05 | 2014-08-27 | ImmunoVaccine Technologies Inc. | Zusammensetzungen mit liposomen, einem antigen, einem polynucleotid und einem träger mit einer kontinuierlichen phase einer hydrophoben substanz |
PL2396006T3 (pl) | 2009-02-16 | 2013-06-28 | Zoetis Llc | Preparat zawierający doramektynę w dużej dawce |
US8313752B2 (en) * | 2009-04-14 | 2012-11-20 | Merial Limited | Macrocyclic lactone combination compositions, vaccines and methods for producing same |
KR102148624B1 (ko) | 2009-09-28 | 2020-08-26 | 인타르시아 세라퓨틱스 인코포레이티드 | 실질 항정상태 약물 전달의 신속 확립 및/또는 종결 |
WO2011043962A2 (en) * | 2009-10-07 | 2011-04-14 | Wyeth Llc | Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
NZ594610A (en) * | 2011-08-16 | 2013-03-28 | Virbac New Zealand Ltd | Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants |
CN113876945A (zh) | 2011-10-06 | 2022-01-04 | 免疫疫苗技术有限公司 | 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用 |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
KR20240042548A (ko) | 2015-06-03 | 2024-04-02 | 인타르시아 세라퓨틱스 인코포레이티드 | 임플란트 배치 및 제거 시스템들 |
CN109310743A (zh) | 2016-05-16 | 2019-02-05 | 因塔西亚制药公司 | 胰高血糖素受体选择性多肽及其使用方法 |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
KR20190104039A (ko) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법 |
US11077134B1 (en) | 2020-11-10 | 2021-08-03 | Mountain Valley Md Inc | Water dissolvable macrocyclic lactone cyclodextrin complexes |
US11638714B2 (en) | 2020-11-10 | 2023-05-02 | Mountain Valley Md Inc | Water dissolvable macrocyclic lactone cyclodextrin complexes |
CN114642632A (zh) * | 2022-02-25 | 2022-06-21 | 河北科技大学 | 一种莫西克汀注射液及其制备方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1143545A (en) | 1965-03-25 | 1969-02-26 | Wellcome Found | Injectable vaccine emulsions |
GB1171125A (en) | 1966-06-08 | 1969-11-19 | Glaxo Lab Ltd | Improvements in or relating to Injectable Preparations |
SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US4093629A (en) | 1977-04-11 | 1978-06-06 | Merck & Co., Inc. | Derivatives of antibiotic substance milbemycin and processes therefor |
NZ186851A (en) | 1977-04-11 | 1984-12-14 | Merck & Co Inc | Glycosyloxy derivatives of milbemycin and parasiticidal compositions |
SU627611A1 (ru) | 1977-09-30 | 1980-02-05 | В.П. Землякова | Вакцинный препарат в.п. земл ковой против клостридиозов животных и птиц |
PH15982A (en) | 1977-10-03 | 1983-05-18 | Merck & Co Inc | Selective hydrogenation producta of c-076 compounds and derivatives thereof |
US4199569A (en) | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
NZ188459A (en) | 1977-10-03 | 1982-09-07 | Merck & Co Inc | Derivatives of c-076 compounds and pesticidal compositions |
IE48627B1 (en) * | 1978-09-11 | 1985-04-03 | Ici Tasman Ltd | Injectable composition for the treatment,of helminthiasis and clostridial diseases in animals |
ZA803063B (en) | 1979-05-31 | 1981-05-27 | Ici Australia Ltd | Process |
JPS57139012A (en) | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
US4606918A (en) | 1983-08-22 | 1986-08-19 | Syntex (U.S.A.) Inc. | Polyoxypropylene-polyoxyethylene block polymer based adjuvants |
US4781920A (en) | 1984-11-13 | 1988-11-01 | American Cyanamid Company | Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole |
US4784845A (en) | 1985-09-16 | 1988-11-15 | American Cyanamid Company | Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs |
ES2052173T3 (es) * | 1989-04-11 | 1994-07-01 | Pfizer | Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. |
US5733566A (en) * | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
US5639876A (en) * | 1991-02-12 | 1997-06-17 | Heska Corporation | Nucleic acid molecules encoding novel parasitic helminth proteins |
US5262400A (en) | 1991-06-20 | 1993-11-16 | Merck & Co., Inc. | 4α-substituted avermectin derivatives |
NZ286586A (en) | 1993-05-10 | 1997-10-24 | Merck & Co Inc | Avermectin formulation with polymer carrier, as a parasiticide |
US5550153A (en) * | 1994-11-14 | 1996-08-27 | Kerz; Phillip D. | Method for treating heartworm-infected canines |
SI0750907T1 (en) * | 1995-06-30 | 2002-08-31 | American Cyanamid Company | Stable macrolide and macrolide vaccine compositions |
-
1997
- 1997-06-05 AT AT97924403T patent/ATE252316T1/de not_active IP Right Cessation
- 1997-06-05 WO PCT/NZ1997/000073 patent/WO1997046204A2/en not_active Application Discontinuation
- 1997-06-05 CA CA002259469A patent/CA2259469A1/en not_active Abandoned
- 1997-06-05 DE DE69725745T patent/DE69725745D1/de not_active Expired - Lifetime
- 1997-06-05 AU AU29829/97A patent/AU728221B2/en not_active Withdrawn - After Issue
- 1997-06-05 US US09/214,260 patent/US6214367B1/en not_active Expired - Lifetime
- 1997-06-05 EP EP97924403A patent/EP0928136B1/de not_active Revoked
-
2001
- 2001-02-21 US US09/788,572 patent/US6663879B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1997046204A2 (en) | 1997-12-11 |
AU2982997A (en) | 1998-01-05 |
EP0928136A4 (de) | 2001-11-14 |
AU728221B2 (en) | 2001-01-04 |
US20010014336A1 (en) | 2001-08-16 |
ATE252316T1 (de) | 2003-11-15 |
US6214367B1 (en) | 2001-04-10 |
EP0928136A2 (de) | 1999-07-14 |
WO1997046204A3 (en) | 1998-03-12 |
EP0928136B1 (de) | 2003-10-22 |
CA2259469A1 (en) | 1997-12-11 |
US6663879B2 (en) | 2003-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE252316T1 (de) | Injizierbare zusammensetzungen | |
BRPI9809791B8 (pt) | compostos imuno efetores de fosfato de aminoalquil glucosamina e composições compreendendo os mesmos | |
AR010375A1 (es) | Composiciones endo-ectoparasiticidas | |
LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
DK0915898T3 (da) | Krystalform I af clarithromycin | |
UY24268A1 (es) | Composiciones estables de vacunas para la administración parenteral, método para su utilización | |
TR200003513T2 (tr) | Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları | |
DK1121135T3 (da) | Præparater af beta-glucaner og specifikke immunglobuliner | |
EP1314431A3 (de) | Newcastle-Krankheitsvirus zur therapeutischen Verwendungen | |
PT1157041E (pt) | Anticorpos para terapia e diagnostico de cancro | |
IL73800A0 (en) | Parasiticidal compositions containing ivermectin and their preparation | |
IL94167A (en) | Immunoconjugate targeting 15A8 or ZME-018 antigens and comprising TNF or interleukin-1 | |
EA200100224A1 (ru) | Комбинированная терапия в-клеточных лимфом, предусматривающая введение антитела против cd20 | |
AU2275397A (en) | Troponin subunits and fragments useful as angiogenesis inhibitors | |
BR9908391A (pt) | Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina | |
BR0215392A (pt) | Composições farmacêuticas compreendendo um inibidor de fosfodiesterase multifuncional e um inibidor de absorção de adenosina, bem como uso das mesmas | |
BR9604825A (pt) | Citostáticos modificados por carboidratos | |
AU2005099A (en) | Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections | |
ES2157886T3 (es) | Composiciones tensioactivas y procedimientos. | |
AR003176A1 (es) | Una composicion farmaceutica para inhibir el crecimiento de cancer | |
BR9900114A (pt) | Composições de ciclodextrina. | |
EP1834670A3 (de) | Avermectinen oder Milbemycine und bis-Aryl-Derivate enthaltende Anthelminthische Zusammensetzungen. | |
MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
ES2182920T3 (es) | Formulaciones solubles de 2-cloro02'-deoxiadenosina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |